Antibodies and related products are the fastest growing class of therapeutic agents. By analysing the regulatory approvals of IgG-based biotherapeutic agents in the past 10 years, we can gain ...

Fresh off winning a Nobel Prize last year, and previously tackling antibodies and peptides, the University of Washington’s ...

Biomissile Pharmaceuticals Co. Ltd. is developing multispecific antibodies that overcome resistance associated with antibody-drug conjugates via its next-generation natural killer (NK) cell engagers.

Nona Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND" (I to ITM), announced ...

The Vancouver-based company uses generative AI to create biologic drugs, with 20 “active programs” underway, many of them ...

A research team from POSTECH has developed a biodegradable polymer-based delivery system that efficiently transports mRNA.

Investigators from Shanghai, China, report responses above 90% by using levantinib and tislelizumab to treat patients with a ...

Now, a new class of drugs may be emerging to challenge the dominance of these first generation checkpoint inhibitors. Experts said a certain type of bispecific antibody seems to have hit upon a ...

The Institute for Protein Innovation (IPI), a nonprofit research institute dedicated to advancing protein science, today announced that it received a $500,000 grant from the Chan Zuckerberg Initiative ...